Supplemental Experimental Procedures
Biochemical and functional analyses.
SDS-and native-PAGE used a PhastSystem apparatus (GE Healthcare), homogenous 12.5% and 7.5% gels, respectively, migration towards the anode and Coomassie blue staining. The SDS-PAGE samples were boiled for 5 min in the presence of 2.5% (w/v) SDS with (reducing conditions) or without (non-reducing conditions) 5% (v/v) β-mercaptoethanol. Native-PAGE mobility shift assays used Fab-EeAChE or Fab-HuBChE complexes formed in solution at a ~1:1 molar ratio (3 h incubation, room temperature). Isoelectric focusing used the same apparatus and pI 3-9 gels.
MALDI-TOF MS was performed on a Voyager-DE TM RP BioSpectrometer Workstation (Perseptive Biosystems) in the positive linear mode using ~10 pmol/0.5 µl samples mixed with, as a matrix, 0.5 µl of sinapinic acid at 10 mg/ml in TFA/acetonitrile/water 0.1:0.6:0.3 (v/v/v) , and the dried-droplet method. The samples were desorbed with a 337 nm nitrogen laser.
AChE activities were recorded for 5 min in duplicate or triplicate on a UNICAM 8700 spectrophotometer (Thermo Optek) using 10 pM EeAChE, 1.25 mM acetylthiocholine iodide (~10 x Km) and 0.33 mM dithiobis(2-nitro-benzoic acid) in 100 mM sodium phosphate, pH 8.0, 0.1mg/ml BSA (λ = 412 nm) [S16] . The Fab/AChE mixtures were incubated overnight (equilibrium analysis) or for selected time intervals (kinetics analysis) under mild agitation at room temperature before recording of fractional activity. Data analysis used GraphPad Prism 4.0.
N-linked carbohydrate removal.
Deglycosylation of the EeAChE tetramer (~3 mg/ml) in native conditions was performed in buffer A using PNGaseF (1,800,000 U.mg -1 ) from BioLabs, a PNGaseF-to-tetramer ratio of 1:200 (w/w) and overnight incubation at 25°C. A control sample for protein integrity was incubated in the absence of PNGaseF. A control sample for total deglycosylation was prepared on denatured and reduced EeAChE: briefly, the EeAChE tetramer (~20 µg in 6.25 µl buffer A) was boiled for 10 min in the presence of 40 mM DTT and 0.5% (w/v) SDS, cooled down, added with 1% (v/v) Nonidet P-40, then incubated in the presence of PNGaseF (~2 µg, 3600 U) for 1 h at 37°C. The native and reduced deglycosylated samples were analyzed comparatively with the unaltered native enzyme by SDS-PAGE in reducing conditions and native-PAGE.
Crystallization of Fab408 and data collection.
Crystallization was achieved at 20°C by vapor diffusion using Fab408 at 10 mg/ml, 1 µl hanging drops and a protein-to-well solution ratio of 1:1. Plate crystals grew spontaneously within 2 days with 18% (v/v) PEG-6000 in 100 mM Na cacodylate, pH 6.0, as the well solution. Crystals were flash-cooled in the nitrogen gas stream after successive short soaks in the well solution supplemented with 7.5%, 15% and 25% (v/v) glycerol, and were stored in liquid nitrogen. Diffraction data were collected at 100 K at the ESRF (Grenoble, France), processed with XDS [S17], and scaled and merged with SCALA. Despite the numerous attempts, no suitable crystals were obtained from Fab403 and Fab410. Supplemental Table   Table S1 . 1  5  10  15  20  E  I  F  L  T  Q  S  P  A  I  I  A  A  S  P  G  E  K  V  T  I  T  C  VL403 gaa att ttt ctc acc cag tct cca gca atc ata gct gca tct cct ggg gag aag gtc acc atc acc tg L AJ231224 Musmus IGKV4-90*01 F - 
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a ata gag gac tgg tac ttc gat gtc tgg ggc aca ggg acc acg gtc acc gtc tcc tca AC079181 Musmus IGHV1-42*01 F (Figure S1 A, part 2) VL 410 1  5  10  15  20  Q  I  V  L  T  Q  S  P  A  I  M  S  A  S  P  G  E  K  V  T  M  T  C  VL410 caa att gtt ctc acc cag tct cca gca atc atg tct gca tct cca ggg gag aag gtc acc atg acc tg I S AJ231209 Musmus IGKV4-61*01 F -------------------... ... ... ... ... ... ... --------------------g ------ -----------c ------------------------... ... ... ... ... ... ... ----------- 
<---------------------------------------------FR1 -IMGT ------------------------------
--------------------------------------------------------------a t----------------> __________________ CDR1 -IMGT ______________ <--------------------------
FR2 -IMGT -------------------------> ______________ CDR2 -IMGT __________ <---------
-------------------------------------------------------------FR3 -IMGT ---------------
---------------------a--------------------------------------------------------> ___________ CDR3 -IMGT ________
--------a-------t --------------------------------t c-----t----a ccc -
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atg aac aac ctg aaa act gag gac aca gcc atg tat tac tgt gtg aga gaa ggg agt tac tac gat ag Figure S2 . Sequence alignment of the AChE species cited in this study. The sequences of the EeAChE, TcAChE, BfAChE and mAChE subunits are displayed. The residue numbering displayed below the alignment is that of EeAChE, while the residue numbering and secondary structure elements displayed above the alignment are those of mAChE. Conserved residues are shown on a black background and non-conserved residues on a white background. The symbols below the alignment point to: the catalytic triad residues (stars); EeAChE Asn residues that belong to consensus N-glycosylation sequences (black dots) [48] ; EeAChE residues whose substitution by rat AChE residues abolished Elec403 binding (Ser75, Gln279, Leu282; black squares), Elec410 binding (Ser75) or Elec408 binding (Leu491, Glu494; white dots) [33] ; and EeAChE residues found to be buried at the interface of the theoretical Fab403-EeAChE complex (triangles). 
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